NeuralCipher Source record
The rate of progression of Parkinson's disease. A longitudinal [18F]DOPA PET study.
PMID: 8615162
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
106.961 articles found
Source record
Basal ganglia function during normal and parkinsonian movement. PET activation studies.
PMID: 8615163
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Fluorodopa PET scanning in Parkinson's disease.
PMID: 8615165
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Striatal dopamine D2 receptor alterations and response to L-DOPA in Parkinson's disease. A [123I]IBZM SPET study.
PMID: 8615167
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Controversies in the therapy of Parkinson's disease.
PMID: 8615168
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Treatment of Parkinson's disease with controlled-release Carbidopa/L-DOPA.
PMID: 8615169
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Contribution of dopaminergic and glutamatergic mechanisms to the pathogenesis of motor response complications in Parkinson's disease.
PMID: 8615171
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Effects of L-DOPA on spatiotemporal contrast sensitivity in Parkinson's disease.
PMID: 8615172
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
New drugs in the treatment of Parkinson's disease. An introduction.
PMID: 8615173
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
A study on the effect and tolerance of lisuride on Parkinson's disease.
PMID: 8615174
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
A placebo-controlled study of ropinirole, a new D2 agonist, in the treatment of motor fluctuations of L-DOPA-treated parkinsonian patients.
PMID: 8615176
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Preclamol. A "designer drug" in the treatment of advanced Parkinson's disease.
PMID: 8615177
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.